David is the Co-founder, Chairman and Chief Executive of Alcentra and chairs the Alcentra European Investment Committee. David also sits on the Executive Committee of BNY Mellon Investment Management and the BNY Mellon Operating Committee.
Prior to founding Alcentra, David worked at Barclays Capital from 1995 to 2003 where he was Managing Director, Founder and Chief Investment Officer of Barclays Capital Asset Management, a wholly owned subsidiary of Barclays Group Plc and the predecessor firm of Alcentra. Whilst he was at Barclays he also set up the par loan trading business and served as a Director of the Loan Market Association (LMA) and chaired the LMA Valuation Committee.
David worked at Bankers Trust from 1992 to 1995, where he was a Vice President and head of European leveraged loan distribution. Prior to that he worked at Chemical Bank from 1987 to 1992 in New York and London, in the structured finance and loan syndication departments.
David is Chairman and Founder of the DFN Charitable Foundation; Trustee of Operation Smile UK; and Trustee of the Isabel Medical Charity.
David graduated from Birmingham University with a BSc (Hons) in Chemical Engineering.
Norman Stromsoy, Adv.DipSE, MA was appointed CEO of DFN Charitable Foundation in June 2015. Previously a special education teacher working with students across the age range with a wide range of special needs, Norman was also a very successful headteacher for 26 years, working in both the state and charity sector with six distinctly different schools, all of which were judged outstanding.
During his career he oversaw the development of a wide range of services providing outreach support, disability sport development and training for professional colleagues and families both in the UK and abroad. He has been responsible for building five schools and centres, which has dramatically improved the provision of services for students with special needs and their families.
As a headteacher and Ofsted Inspector he worked effectively with colleagues to ensure students achieved outstanding progress and attainment. Until recently he was Interim CEO of Stepping Stones Special School in Hindhead, Surrey, where he has overseen the transformational change which has allowed the building of the new school based at Undershaw, Conan Doyles old home.
As CEO of the DFN Charitable Foundation he will provide professional advice and guidance to Trustees to enable the charity to achieve its goals.
James has been an investment manager in the City for the last 22 years. Over the last eight years he has been Governor at three schools and also an academy chain. He brings a deep understanding of the education system in the UK. James also spent a year teaching English in Pakistan.
David Tosh is a Director at RBC Wealth Management based in the City of London and joined the Royal Bank of Canada in 2014. He is responsible for providing integrated wealth management services to a range of different clients. Until his current position David worked for Barclays for 29 years across the Corporate, Retail and Wealth divisions. This included 15+ years' experience with Barclays Wealth.
David is a member of The Chartered Institute for Securities and Investment and is ACIB qualified.
In his 20's David played rugby union for London Scottish and the Anglo-Scots having earlier been selected for the national Scotland Under 21 squad. David is married with 3 children and lives in Hampshire. He is a school governor.
Simon is a Partner of Clyde & Co, LLP and heads up the firm's insurance practice. He also sits on their global board. Prior to this Simon was a Senior Partner at Barlow, Lyde & Gilbert LLP. Simon is married with 3 children.
Eric has worked in the field of medical research charities for over 20 years. He founded Myeloma UK in 1996 and was their Chief Executive until February 2017. Currently, Eric combines working for the Amyloidosis Research Consortium as their Head of Global Strategy with a consultancy business specialising primarily in market access and evidence development strategies.
Eric describes himself as incredibly committed and focused on improving patient outcomes and puts patients at the centre of everything he does. His career goal is to have made a significant and material impact on the quality of life of patients and the prevention and curability of rare diseases.
Central to achieving this, Eric has a strong track record of delivery and success in building multi-stakeholder research collaborations and consortia, and delivering innovative solutions to complex issues challenges and barriers standing in the way of progress.
Eric also holds several board, honorary, advisory and voluntary positions and advises numerous medical and health-focused charities on a pro bono basis. He was awarded an OBE for services to charity in the Queen’s Birthday Honours 2012.